CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 37.60
-1.25 (-3.22%)
Aug 12, 2025, 1:51 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 8.13 billion as of August 11, 2025. Its market cap has decreased by -41.54% in one year.
Market Cap
8.13B
Enterprise Value
5.80B
Revenue
3.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.60
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 8.13B, a decrease of -45.78%. That is a compound annual growth rate of -7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 8.13B | -26.21% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | 4.57B | 3.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |